用肉毒素治疗中风后性的长期管理:一项回顾性研究
Nicoletta Falcone1, Fabrizio Leo2, Carmelo Chisari1
1Department of Traslational Research and New Technologies in Medicine and Surgery, Unit of Neurorehabilitation, University of Pisa, 56126 Pisa, Italy.
Toxins
|September 27, 2024
概括
长期的肉毒素A注射用于中风性,随着时间的推移,间隔和剂量增加. 早期开始治疗和明确的患者目标对于有效管理这种慢性疾病至关重要.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 脑卒中引起的性严重影响了幸存者的生活质量.
- 毒素A (BoNT-A) 是一种常见的治疗方法,但长期的结果尚不清楚.
- 对于慢性中风后的最佳管理策略需要进一步调查.
研究的目的:
- 分析慢性中风患者的长期肉毒素A治疗模式.
- 评估治疗持续时间,剂量变化和断学率.
- 了解BoNT-A在长时间内的性管理的演变.
主要方法:
- 追溯分析95名慢性中风患者的医疗记录.
- 包括2至14年持续BoNT-A治疗性的患者.
- 评估人口统计数据,治疗间隔,剂量调整和停止治疗的原因.
主要成果:
- 在治疗期间观察到BoNT-A注射间隔的显著延长.
- 学率在前5年内是最高的,这可能与感知到的无效性有关.
- 在各个患者群体中发现了增加BoNT-A剂量的趋势,这表明性或治疗反应正在演变.
- BoNT-A仍然是中风后性的主要治疗方法.
结论:
- 脑卒中后性的长期BoNT-A治疗包括剂量和注射频率的动态变化.
- 延迟启动BoNT-A治疗强调了需要提高提供者的意识.
- 确定患者的期望和监测长期结果对于优化坚持和有效管理性至关重要.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...


